Weaponizing CRISPR/Cas9 for selective elimination of cells with an aberrant genome

ABSTRACT: RNA-seq profiling of HeLa GFP cells treated with a Cas9 bearing either a scramble or a GFP guide to study the activation of inflammatory pathways 3 days after Cas9 delivery

INSTRUMENT(S): NextSeq 550

ORGANISM(S): Homo sapiens

SUBMITTER:  

PROVIDER: E-MTAB-14730 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP167413

REPOSITORIES: biostudies-arrayexpress